건병증 시장 보고서(2025년)

Tendinopathy is a condition that affects the tendons, leading to pain, swelling, and reduced movement or strength. It is typically caused by repetitive stress or overuse, resulting in the deterioration of tendon tissue rather than acute inflammation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of tendinopathy include Achilles tendinopathy, rotator cuff tendinopathy, lateral epicondylitis (tennis elbow), patellar tendinopathy, and others. Achilles tendinopathy specifically refers to an injury to the Achilles tendon, which connects the calf muscles to the heel bone. Treatment options for tendinopathy include therapy, medications, surgical interventions, and regenerative medicine approaches. The condition can be managed using various routes of administration, such as oral, topical, and injectable methods. These treatments are provided in various healthcare settings, including hospitals, clinics, and ambulatory surgical centers.

The tendinopathy market research report is one of a series of new reports from The Business Research Company that provides tendinopathy market statistics, including the tendinopathy industry global market size, regional shares, competitors with the tendinopathy market share, detailed tendinopathy market segments, market trends, and opportunities, and any further data you may need to thrive in the tendinopathy industry. This tendinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tendinopathy market size has grown strongly in recent years. It will grow from$12.63 billion in 2024 to $13.32 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to several factors, including the rising incidence of sports-related injuries, a growing aging population, increased awareness of musculoskeletal disorders, the expanding availability of physical therapy services, and greater healthcare spending globally.

The tendinopathy market size is expected to see strong growth in the next few years. It will grow to$16.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth during the forecast period can be attributed to several factors, including increasing participation in sports and fitness activities, a rising geriatric population, growing awareness of early tendon injury management, the increasing availability of minimally invasive procedures, expanding healthcare infrastructure, and the rising adoption of wearable devices for musculoskeletal monitoring. Major trends expected during this period include the adoption of regenerative therapies, the development of biologics for tendon repair, advancements in minimally invasive surgical techniques, innovations in wearable devices for rehabilitation monitoring, improvements in pain management formulations, and the integration of AI-driven diagnostic tools.

The growing incidence of sports injuries is expected to drive the expansion of the tendinopathy market. Sports injuries refer to physical injuries sustained during athletic activities or exercise, ranging from minor sprains and strains to more severe fractures or dislocations. The rise in sports injuries is linked to increased training intensity and competition at younger ages, which places excessive stress on developing muscles and joints before they are fully matured. These injuries can lead to tendinopathy by subjecting tendons to repetitive stress or sudden overload, causing microscopic tears, inflammation, and degeneration over time. For example, in November 2023, Howden Group Holdings Ltd., a UK-based insurance intermediary company, reported that the severity of ankle injuries in the English Premier League increased by 170% between October 2022 and January 2023, while calf/shin injuries surged by 200% and hamstring injuries rose by 130%, following the FIFA World Cup Qatar 2022. As such, the rising incidence of sports injuries is contributing to the growth of the tendinopathy market.

Leading companies in the tendinopathy market are focusing on developing advanced products, such as bioinductive implants, to accelerate healing, improve tendon regeneration, and reduce recovery time. Bioinductive implants are innovative medical devices that stimulate the body's natural healing process by promoting the growth of tendon-like tissue, leading to improved clinical outcomes in tendon repair. For example, in July 2023, Smith+Nephew, a UK-based medical technology company, launched the REGENETEN Bioinductive Implant in India. This collagen-based device transforms tendon repair by encouraging biological healing through the induction of new tissue growth at the injury site, particularly for rotator cuff repairs. A key feature of the implant is its minimally invasive delivery method, which allows orthopedic surgeons to biologically reinforce the tendon without changing existing surgical techniques, offering a quicker, safer, and more effective treatment option for tendinopathy patients.

In April 2023, Vander-Bend Manufacturing, Inc., a U.S.-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. With this acquisition, Vander-Bend aims to expand its precision manufacturing capabilities, enhance its product offerings in the medical technology sector, and strengthen its position in the market by integrating Omni Components Corporation's expertise in producing complex, high-precision components. Omni Components Corporation is a U.S.-based medical device company specializing in tendon surgeries.

Major players in the tendinopathy market are Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GSK plc, Medtronic Plc, 3M Company, Stryker Corporation, Teva Pharmaceutical Industries, Zimmer Biomet, Smith & Nephew plc, Coloplast A/S, Arthrex, Bioventus, Tynor Orthotics, Almatica Pharma Inc.

North America was the largest region in the tendinopathy market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tendinopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tendinopathy market consists of revenues earned by entities by providing services such as physical therapy and rehabilitation programs, pain management, arthroscopic debridement, and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The tendinopathy market also include sales of nonsteroidal anti-inflammatory drugs, creams and gels, and capsaicin creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tendinopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tendinopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tendinopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tendinopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Achilles Tendinopathy; Rotator Cuff Tendinopathy; Lateral Epicondylitis (Tennis Elbow); Patellar Tendinopathy; Other Types
• 2) By Treatment Type: Therapy; Medication; Surgical Treatment; Regenerative Medicine
• 3) By Route Of Administration: Oral; Topical; Injectable
• 4) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Rehabilitation Centers
• Subsegments:
• 1) By Achilles Tendinopathy: Insertional Achilles Tendinopathy; Non-insertional Achilles Tendinopathy
• 2) By Rotator Cuff Tendinopathy: Supraspinatus Tendinopathy; Infraspinatus Tendinopathy; Subscapularis Tendinopathy; Teres Minor Tendinopathy
• 3) By Lateral Epicondylitis (Tennis Elbow): Tendon Overuse Injuries; Tendon Degeneration Injuries
• 4) By Patellar Tendinopathy: Proximal Patellar Tendinopathy; Distal Patellar Tendinopathy
• 5) By Other Types: De Quervain's Tenosynovitis; Peroneal Tendinopathy; Flexor Tendinopathy; Extensor Tendinopathy
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tendinopathy Market Characteristics

3. Tendinopathy Market Trends And Strategies

4. Tendinopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tendinopathy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tendinopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tendinopathy Market Growth Rate Analysis
• 5.4. Global Tendinopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tendinopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tendinopathy Total Addressable Market (TAM)

6. Tendinopathy Market Segmentation

• 6.1. Global Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Achilles Tendinopathy
• Rotator Cuff Tendinopathy
• Lateral Epicondylitis (Tennis Elbow)
• Patellar Tendinopathy
• Other Types
• 6.2. Global Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapy
• Medication
• Surgical Treatment
• Regenerative Medicine
• 6.3. Global Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Injectable
• 6.4. Global Tendinopathy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Rehabilitation Centers
• 6.5. Global Tendinopathy Market, Sub-Segmentation Of Achilles Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insertional Achilles Tendinopathy
• Non-insertional Achilles Tendinopathy
• 6.6. Global Tendinopathy Market, Sub-Segmentation Of Rotator Cuff Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Supraspinatus Tendinopathy
• Infraspinatus Tendinopathy
• Subscapularis Tendinopathy
• Teres Minor Tendinopathy
• 6.7. Global Tendinopathy Market, Sub-Segmentation Of Lateral Epicondylitis (Tennis Elbow), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tendon Overuse Injuries
• Tendon Degeneration Injuries
• 6.8. Global Tendinopathy Market, Sub-Segmentation Of Patellar Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proximal Patellar Tendinopathy
• Distal Patellar Tendinopathy
• 6.9. Global Tendinopathy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• De Quervain's Tenosynovitis
• Peroneal Tendinopathy
• Flexor Tendinopathy
• Extensor Tendinopathy

7. Tendinopathy Market Regional And Country Analysis

• 7.1. Global Tendinopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tendinopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tendinopathy Market

• 8.1. Asia-Pacific Tendinopathy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tendinopathy Market

• 9.1. China Tendinopathy Market Overview
• 9.2. China Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tendinopathy Market

• 10.1. India Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tendinopathy Market

• 11.1. Japan Tendinopathy Market Overview
• 11.2. Japan Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tendinopathy Market

• 12.1. Australia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tendinopathy Market

• 13.1. Indonesia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tendinopathy Market

• 14.1. South Korea Tendinopathy Market Overview
• 14.2. South Korea Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tendinopathy Market

• 15.1. Western Europe Tendinopathy Market Overview
• 15.2. Western Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tendinopathy Market

• 16.1. UK Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tendinopathy Market

• 17.1. Germany Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tendinopathy Market

• 18.1. France Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tendinopathy Market

• 19.1. Italy Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tendinopathy Market

• 20.1. Spain Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tendinopathy Market

• 21.1. Eastern Europe Tendinopathy Market Overview
• 21.2. Eastern Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tendinopathy Market

• 22.1. Russia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tendinopathy Market

• 23.1. North America Tendinopathy Market Overview
• 23.2. North America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tendinopathy Market

• 24.1. USA Tendinopathy Market Overview
• 24.2. USA Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tendinopathy Market

• 25.1. Canada Tendinopathy Market Overview
• 25.2. Canada Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tendinopathy Market

• 26.1. South America Tendinopathy Market Overview
• 26.2. South America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tendinopathy Market

• 27.1. Brazil Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tendinopathy Market

• 28.1. Middle East Tendinopathy Market Overview
• 28.2. Middle East Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tendinopathy Market

• 29.1. Africa Tendinopathy Market Overview
• 29.2. Africa Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tendinopathy Market Competitive Landscape And Company Profiles

• 30.1. Tendinopathy Market Competitive Landscape
• 30.2. Tendinopathy Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Tendinopathy Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. Novartis AG
• 31.4. GSK plc
• 31.5. Medtronic Plc
• 31.6. 3M Company
• 31.7. Stryker Corporation
• 31.8. Teva Pharmaceutical Industries
• 31.9. Zimmer Biomet
• 31.10. Smith & Nephew plc
• 31.11. Coloplast A/S
• 31.12. Arthrex
• 31.13. Bioventus
• 31.14. Tynor Orthotics
• 31.15. Almatica Pharma Inc.

32. Global Tendinopathy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tendinopathy Market

34. Recent Developments In The Tendinopathy Market

35. Tendinopathy Market High Potential Countries, Segments and Strategies

• 35.1 Tendinopathy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tendinopathy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tendinopathy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34990_Tendinopathy_GMR_2025